Thanks for the reply, Steady. To some extent, I agree with you; however, long-term also need to be responsible for themselves, too. E.g., don't let the bashers take over 'our' message board. We need to ignore them and just carry on with our reasonable exchanges of info and ideas. Many longs go edge-triggered and ridiculous in attacking anybody who doesn't have a massively rosy outlook for the very near term as 'part of the shorting conspiracy yada yada.' In other words, be a bit discerning before jumping to conclusions. That is on the longos. Frankly, I could also get a little bit paranoid that someone might be trying to push longs into expecting instant sky-high valuations and bid the price up too much on positive news, and let the shorts step back in when the price runs 'too much'. As you know, we have seen lots of volatility, 'run up then fall right back' type scenarios. In any case, biotech companies are inherently boom or bust type, high-risk risk high-reward stocks, so whatcha gonna do? I certainly have seen longs who have been around for a long time get paranoid and nasty toward anybody who expresses any negative or reservation or expresses any less than hugely positive expectations for the very near term. 'What, only ten times gain? You gotta be a short pretending to be long.' Some believe that NW will sell 10 times the entire GBM population of the UK in the first year of commercial sales, when authorized only to market in the UK. That doesn't make any sense to me, and I can only imagine that they will start to feel 'cheated' if the stock doesn't run to the moon right away upon commercial approval. I hope that DcVax-L will soon get to be SOC for GBM in the UK, but who knows how long that will take? It won't be immediate upon approval of the MAA, that is certain. Longs who have been in the stock since 2022 ought to have tempered any excessive expectations of instant massive riches, but who knows? To talk of anything less is considered treasonous.
Market Data 
Markets 
